Work

A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector

Year: 2022

Type: article

Source: Journal of Molecular and Cellular Cardiology

DOI: 10.1016/j.yjmcc.2022.08.225

Authors: Monica Alvisi, Timothy Henry, Eugene Chung, Jay Traverse, Leigh Ervin, Shiva Krupa, Hesham Sadek, Canwen Jiang, Sheila Mikhail, Kobra Haghighi, Evangelia Kranias, Jude Samulski, Anna Tretalova, Roger Hajjar

Institutions: Christ Hospital, Minneapolis Heart Institute Foundation, AskBio (United States), The University of Texas Southwestern Medical Center, University of Cincinnati, Flagship Pioneering (United States)

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313397361

FWCI: 0.27

Cites:

Cited by: 4

Related to: 10